Status In progress
Process CDF Review
ID number 1572

Provisional Schedule

Expected publication 06 May 2020

Project Team

Project lead Louise Jafferally

Email enquiries


Companies sponsors Bristol-Myers Squibb
Others Department of Health and Social Care
  NHS England
  NHS Havering CCG
  NHS Sandwell and West Birmingham CCG
  Welsh Government
Patient carer groups Black Health Agency
  British Lung Foundation
  Cancer Black Care
  Cancer Equality
  Equalities National Council
  Helen Rollason Cancer Charity
  Independent Cancer Patients Voice
  Macmillan Cancer Support
  Maggie’s Centres
  Marie Curie Cancer Care
  Muslim Council of Britain
  Roy Castle Lung Cancer Foundation
  South Asian Health Foundation
  Specialised Healthcare Alliance
  UK Lung Cancer Coalition
Professional groups Association of Anaesthetists
  Association of Cancer Physicians
  Association of Respiratory Nurse Specialists
  Association of Surgeons of Great Britain and Ireland
  British Geriatrics Society
  British Institute of Radiology
  British Psychosocial Oncology Society
  British Society of Interventional Radiology
  British Thoracic Oncology Group
  British Thoracic Society
  Cancer Research UK
  National Heart and Lung Institute
  National Lung Cancer Forum for Nurses
  Primary Care Respiratory Society UK
  Royal College of Anaesthetists
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal College of Radiologists
  Royal College of Surgeons
  Royal Pharmaceutical Society
  Royal Society of Medicine
  Society and College of Radiographers
  UK Clinical Pharmacy Association
  UK Health Forum
  UK Oncology Nursing Society


Assessment group Public Health England
  Public Health Wales
Associated guideline groups National Guideline Alliance
Comparator companies Accord Healthcare
  Boehringer Ingelheim
  Consilient Health
  Hospira UK
  Lilly UK
  Medac UK
  Novartis Pharmaceuticals
  Pierre Fabre
  Roche Products
  Seacross Pharmaceuticals
  Sun Pharmaceuticals
Evidence review group Liverpool Reviews and Implementation Group (LRIG)
General commentators All Wales Therapeutics and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare Products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Alliance
  NHS Commercial Medicines Unit
  NHS Confederation
  Scottish Medicines Consortium
  Welsh Health Specialised Services Committee
Relevant research groups Cochrane Lung Cancer Group
  Genomics England
  Institute of Cancer Research
  MRC Clinical Trials Unit
  National Cancer Research Institute
  National Cancer Research Network
  National Institute for Health Research


Key events during the development of the guidance:

Date Update
18 March 2020 Committee meeting: 1
06 December 2019 Appraisal in progress.
03 September 2019 This appraisal topic is paused to allow the company to provide updated submission documentation. The appraisal will be rescheduled into the work programme and the updated appraisal timelines will be communicated, once known.
19 July 2019 Invitation to participate
11 July 2019 In progress, Start date of invitation to participate

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance